| PMID:23611580 |
Reversible inhibition of calcium oxalate monohydrate growth by an osteopontin phosphopeptide. |
2013 |
| PMID:21883862 |
The effect of intracrystalline and surface-bound osteopontin on the attachment of calcium oxalate dihydrate crystals to Madin-Darby canine kidney (MDCK) cells in ultrafiltered human urine. |
2011 |
| PMID:19189038 |
Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy. |
2009 |
| PMID:19581305 |
Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning. |
2009 |
| PMID:18728346 |
Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals. |
2008 |
| PMID:17994739 |
Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide. |
2007 |
| PMID:14766970 |
Molecular modulation of calcium oxalate crystallization by osteopontin and citrate. |
2004 |
| PMID:12706004 |
The role of osteopontin on calcium oxalate crystal formation. |
2003 |
| PMID:9453018 |
Contribution of human uropontin to inhibition of calcium oxalate crystallization. |
1998 |
| PMID:8839390 |
Identification of a macromolecular crystal growth inhibitor in human urine as osteopontin. |
1995 |
| PMID:1414495 |
The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. |
1992 |